These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34531269)

  • 41. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
    Zanichelli V; Huttner A; Harbarth S; Kronenberg A; Huttner B; Swiss Centre For Antibiotic Resistance Anresis
    Swiss Med Wkly; 2019 Jul; 149():w20110. PubMed ID: 31340052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
    Karlowsky JA; Adam HJ; Desjardins M; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i39-46. PubMed ID: 23587777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priming effect with photoinactivation against extensively drug-resistant Enterobacter cloacae and Klebsiella pneumoniae.
    Woźniak A; Burzyńska N; Zybała I; Empel J; Grinholc M
    J Photochem Photobiol B; 2022 Oct; 235():112554. PubMed ID: 36095975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.
    Wong PH; von Krosigk M; Roscoe DL; Lau TT; Yousefi M; Bowie WR
    BMC Infect Dis; 2014 Oct; 14():393. PubMed ID: 25308184
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
    Menegucci TC; Bastos MS; Viana GF; Moreira RRB; Garcia LB; Cardoso CL; Tognim MCB
    J Chemother; 2017 Jun; 29(3):189-194. PubMed ID: 27077929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt.
    Khalaf NG; Eletreby MM; Hanson ND
    BMC Infect Dis; 2009 Jun; 9():84. PubMed ID: 19497111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility.
    Niki Y; Hanaki H; Matsumoto T; Yagisawa M; Kohno S; Aoki N; Watanabe A; Sato J; Hattori R; Koashi N; Terada M; Kozuki T; Maruo A; Morita K; Ogasawara K; Takahashi Y; Matsuda K; Nakanishi K; Sunakawa K; Takeuchi K; Fujimura S; Takeda H; Ikeda H; Sato N; Niitsuma K; Saito M; Koshiba S; Kaneko M; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Aoki Y; Chonabayashi N; Sugiura H; Ichioka M; Goto H; Kurai D; Saraya T; Okazaki M; Yoshida K; Yoshida T; Tsukada H; Imai Y; Honma Y; Yamamoto T; Kawai A; Mikamo H; Takesue Y; Wada Y; Miyara T; Toda H; Mitsuno N; Fujikawa Y; Nakajima H; Kubo S; Ohta Y; Mikasa K; Kasahara K; Koizumi A; Sano R; Yagi S; Takaya M; Kurokawa Y; Kusano N; Mihara E; Nose M; Kuwabara M; Fujiue Y; Ishimaru T; Matsubara N; Kawasaki Y; Tokuyasu H; Masui K; Kido M; Ota T; Honda J; Kadota J; Hiramatsu K; Aoki Y; Nagasawa Z; Yanagihara K; Fujita J; Tateyama M; Totsuka K
    J Infect Chemother; 2011 Aug; 17(4):510-23. PubMed ID: 21409533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of carbapenem-resistant
    Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
    [No Abstract]   [Full Text] [Related]  

  • 52. Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System.
    Pecora ND; Li N; Allard M; Li C; Albano E; Delaney M; Dubois A; Onderdonk AB; Bry L
    mBio; 2015 Jul; 6(4):e01030. PubMed ID: 26220969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.
    Chavda KD; Chen L; Fouts DE; Sutton G; Brinkac L; Jenkins SG; Bonomo RA; Adams MD; Kreiswirth BN
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
    Wang FD; Lin ML; Lee WS; Liu CY
    Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
    Hayami H; Takahashi S; Ishikawa K; Yasuda M; Yamamoto S; Wada K; Kobayashi K; Hamasuna R; Minamitani S; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Masumori N; Nishiyama H; Miyazaki J; Fujimoto K; Tanaka K; Uehara S; Matsubara A; Ito K; Hayashi K; Kurimura Y; Ito S; Takeuchi T; Narita H; Izumitani M; Nishimura H; Kawahara M; Hara M; Hosobe T; Takashima K; Chokyu H; Matsumura M; Ihara H; Uno S; Monden K; Sumii T; Kawai S; Kariya S; Sato T; Yoshioka M; Kadena H; Matsushita S; Nishi S; Hosokawa Y; Shirane T; Yoh M; Watanabe S; Makinose S; Uemura T; Goto H
    J Infect Chemother; 2019 Jun; 25(6):413-422. PubMed ID: 30905628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998).
    Lewis MT; Gales AC; Sader HS; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 May; 37(1):63-74. PubMed ID: 10794943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.
    Jones RN; Kugler KC; Pfaller MA; Winokur PL
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):55-63. PubMed ID: 10529882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.